Liabilities / Assets
74th percentile
Higher debt load relative to assets than 74% of similar nonprofits.
Oregon Biotechnology Associati
990 • Fiscal year 2016 • EIN 93-1009329
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.29x
Liabilities / Revenue
61st percentile
Higher debt load relative to revenue than 61% of similar nonprofits.
Net Margin
14th percentile
Higher net margin than 14% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
56th percentile
Faster asset growth than 56% of similar nonprofits.
Revenue Growth
30th percentile
Faster revenue growth than 30% of similar nonprofits.
Balance Sheet
Assets
Up$412,756
Up $22,877 (+5.9%) from 2015
Net Assets
Down$292,353
Down $78,718 (-21%) from 2015
Liabilities
Up$120,403
Up $101,595 (+540%) from 2015
Revenue And Expenses
Revenue
Down$882,439
Down $30,655 (-3.4%) from 2015
Expenses
Up$961,157
Up $213,470 (+29%) from 2015
Net Income
Down-$78,718
Down $244,125 (-148%) from 2015
Historical Trend
Filing Detail Status
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview
Mission
Promote growth and quality of the Bioscience Industry in Oregon through community collaboration and commercialzation
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2016 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $412,756
- Liabilities
- $120,403
- Net assets
- $292,353
- Revenue
- $882,439
- Expenses
- $961,157
- Net income
- -$78,718